Clinical Trial: Bilateral Dispensing Study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric Lenses
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Bilateral Dispensing Study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric Lenses
Brief Summary: Bilateral dispensing study of MyDay Toric, 1-day Acuvue Moist for Astigmatism, and Dailies Aquacomfort Plus Toric lenses
Detailed Summary: Prospective, double-masked (investigator and participant), bilateral, randomized, cross-over dispensing study comparing the MyDay Toric (test) against the 1-day Acuvue Moist for Astigmatism (control), and Dailies Aquacomfort Plus Toric (control) lenses
Sponsor: Coopervision, Inc.
Current Primary Outcome:
- Comfort [ Time Frame: Up to 1 week follow-up ]Subjective ratings of lens performance for comfort assessed. Comfort Scale 0-10, 0=painful, 10=can't feel the lenses.
- Dryness [ Time Frame: Up to 1 week follow-up ]Subjective ratings of lens performance for dryness assessed. Dryness Scale 0-10, 0=extremely dry, 10=no dryness
- Visual quality [ Time Frame: Up to 1 week follow-up ]Subjective ratings of lens performance for visual quality assessed. Visual quality Scale 0-10, 0=completely dissatisfied, 10=completely satisfied
- Lens preference with respect to overall comfort [ Time Frame: Up to 3 weeks follow-up ]Overall comfort preference of MyDay Toric, 1-Day Acuvue Moist Toric or Dailies Aquacomfort Plus Toric lenses. Scale: Prefer MyDay Toric, 1-Day Acuvue Moist Toric or Dailies Aquacomfort Plus Toric lenses each: strong or slight or no-preference
- Lens preference with respect to visual quality [ Time Frame: Up to 3 weeks follow-up ]Overall vision quality preference of MyDay Toric, 1-Day Acuvue Moist Toric or Dailies Aquacomfort Plus Toric lenses. Scale: Prefer MyDay Toric, 1-Day Acuvue Moist Toric or Dailies Aquacomfort Plus Toric lenses each: strong or slight or no-preference
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Coopervision, Inc.
Dates:
Date Received: April 12, 2017
Date Started: October 19, 2016
Date Completion: June 2017
Last Updated: April 26, 2017
Last Verified: April 2017